Balchem Corporation filings document financial results, governance matters, shareholder votes, and material events for a specialty ingredient manufacturer with Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products segments. Form 8-K reports attach quarterly and annual earnings releases with segment performance, cash flow measures, balance sheet items, debt, and capital-allocation disclosures.
Proxy and shareholder-meeting filings describe board elections, auditor ratification, advisory executive-compensation votes, meeting procedures, corporate governance practices, and executive compensation. Other material-event reports record officer transitions and related governance disclosures, while exhibit and Inline XBRL records support the company’s public reporting framework.
CORP director David B. Fischer reported an acquisition of common stock through a restricted stock award. On February 11, 2026, he received 870 shares at a price of $0, characterized as a grant or award. These restricted shares vest in one year under a Restricted Stock Grant Agreement with the company. Following this transaction, Fischer directly holds 8,859 shares of CORP common stock.
Director Monica Vicente reported an acquisition of CORP common stock through an equity award. On February 11, 2026, she received 870 shares of restricted common stock at a stated price of $0 per share, increasing her direct holdings to 2,390 shares. According to the footnote, this restricted stock will vest in her name one year after the grant date and is subject to transfer restrictions set out in a Restricted Stock Grant Agreement between CORP and Vicente.
CORP vice president and chief accounting officer William A. Backus reported a routine tax-related share withholding. On 02/08/2026, 322 shares of common stock were withheld at $173.16 per share to cover taxes due on the vesting of restricted shares originally granted on 2/8/2023.
After this withholding, Backus beneficially owned 5,517 shares of CORP common stock directly and 283 shares indirectly through a 401(k) plan. The filing reflects administrative share withholding rather than an open-market sale.
BCPC’s executive vice president, chief legal officer, and secretary reported a routine tax-related share withholding. On 02/08/2026, 343 shares of common stock were disposed of at $173.16 per share to cover withholding taxes due upon vesting of restricted shares granted on 02/08/2023.
After this transaction, the officer beneficially owned 5,846 common shares directly and 487 common shares indirectly through a 401(k) plan.
An officer of the issuer with ticker BCPC, SVP and GM, Specialty Products Job Leonard van Gunsteren, reported a routine tax-related share withholding. On February 8, 2026, 258 shares of common stock were withheld at $173.16 per share to cover taxes due on the vesting of restricted shares granted on February 8, 2023.
After this withholding, van Gunsteren directly beneficially owns 9,188 shares of the company’s common stock. The transaction was coded “F,” indicating a tax withholding in connection with an equity award vesting rather than an open-market sale.
Backus William A., VP & Chief Accounting Officer of CORP (BCPC), reported a routine share withholding related to equity compensation. On 04/01/2025, 383 shares of common stock at $167.24 per share were withheld to cover taxes upon vesting of restricted shares granted on 4/1/2022.
After this transaction, he beneficially owned 5,839 common shares directly and 256 common shares indirectly through a 401(k) plan as of 4/1/2025. The report notes it was an inadvertent late filing caused by an administrative error.
Balchem Corporation’s Chairman, President & CEO Theodore L. Harris reported a tax-related share withholding in company stock. On 02/08/2026, 3,225 shares of common stock were withheld at $173.16 per share to cover withholding taxes upon vesting of restricted shares granted on 2/8/2023.
Following this transaction, Harris directly beneficially owns 75,934 shares of common stock. In addition, 2,007 shares are held indirectly through a 401(k) Plan. A further 1,022.58 shares are held in a trust for the benefit of his mother, where he serves as trustee and disclaims beneficial ownership except for any pecuniary interest.
BCPC senior vice president Frederic Boned reported a small tax‑related share withholding tied to equity compensation. On February 8, 2026, 430 shares of common stock were withheld at $173.16 per share to cover taxes on restricted shares granted on February 8, 2023. After this transaction, Boned directly owned 5,215 common shares and indirectly held 441 shares through a 401(k) plan.
BCPC executive Carl Martin Bengtsson, EVP & Chief Financial Officer, reported a routine tax-related share withholding. On February 8, 2026, 863 shares of common stock were withheld at $173.16 per share to cover taxes on vesting restricted shares granted on February 8, 2023.
After this transaction, Bengtsson beneficially owned 22,316 common shares directly and 1,086 common shares indirectly through a 401(k) plan. The filing reflects administrative settlement of equity compensation rather than an open-market sale.
Corp SVP Chief Supply Chain Officer Martin Luther Reid reported an administrative share withholding tied to equity compensation. On 02/08/2026, 416 shares of common stock were withheld at $173.16 per share to cover taxes due on the vesting of restricted shares originally granted on 02/08/2023.
After this transaction, Reid beneficially owns 6,975 common shares directly and 542 common shares indirectly through a 401(k) plan. The filing reflects tax settlement related to stock-based compensation rather than an open-market sale.